KORU Medical Systems, Inc.

Equities

KRMD

US7599101026

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 01:00:00 2024-07-03 pm EDT 5-day change 1st Jan Change
2.54 USD +11.89% Intraday chart for KORU Medical Systems, Inc. -11.19% +3.46%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Koru Medical Systems' FreedomEdge System Receives Regulatory Approval in Japan MT
KORU Medical Systems Receives Regulatory Clearance for FreedomEdge Infusion System in Japan CI
KORU Medical Systems, Inc.(NasdaqCM:KRMD) dropped from Russell 2000 Dynamic Index CI
KORU Medical Systems, Inc.(NasdaqCM:KRMD) dropped from Russell Small Cap Comp Growth Index CI
KORU Medical Systems, Inc.(NasdaqCM:KRMD) dropped from Russell Small Cap Completeness Index CI
KORU Medical Systems, Inc.(NasdaqCM:KRMD) dropped from Russell 3000E Index CI
KORU Medical Systems, Inc.(NasdaqCM:KRMD) dropped from Russell 2500 Growth Index CI
SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion CI
KORU Medical Systems, Inc. Announces Collaboration with Global Pharmaceutical Company to Initiate Feasibility Study with Its Freedom Infusion System for FDA and EMA Approved Subcutaneous Oncology Biologic Drug CI
KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic CI
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q1 Revenue $8.2M, vs. Street Est of $7.5M MT
Transcript : KORU Medical Systems, Inc., Q1 2024 Earnings Call, May 01, 2024
KORU Medical Systems, Inc. reaffirms Financial Guidance for the Full Year of 2024 CI
KORU Medical Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Transcript : KORU Medical Systems, Inc., Q4 2023 Earnings Call, Mar 13, 2024
KORU Medical Systems, Inc. Enters into Loan and Security Agreement with HSBC Ventures USA Inc CI
KORU Medical Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
KORU Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Reports Q4 Revenue $7.2M, vs. Street Est of $6.9M MT
KORU Medical Systems, Inc. Provides Earnings Guidance for the Full Year 2024 CI
KORU Medical Systems, Inc. Announces A Feasibility Study to Enter Ambulatory Infusion Settings with A Commercialized Biologic CI
KORU Medical Systems, Inc. Signs Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for Novel Subcutaneous Immunoglobulin CI
Transcript : KORU Medical Systems, Inc. - Analyst/Investor Day
Transcript : KORU Medical Systems, Inc., Q3 2023 Earnings Call, Nov 08, 2023
Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q3 Revenue $7M, vs. Street Est of $7.9M MT
Chart KORU Medical Systems, Inc.
More charts
KORU Medical Systems, Inc. designs, manufactures, and markets proprietary portable and advanced medical devices primarily for the subcutaneous drug delivery market. The Company is focused on home and specialty infusion solutions. Its focus is primarily concentrated on its mechanical infusion products, the FREEDOM Infusion Systems, which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. The devices are used for infusions administered at home and in alternate care settings. Its infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.54 USD
Average target price
3.5 USD
Spread / Average Target
+37.80%
Consensus
  1. Stock Market
  2. Equities
  3. KRMD Stock
  4. News KORU Medical Systems, Inc.
  5. Koru Medical Systems' FreedomEdge System Receives Regulatory Approval in Japan